Bacitracin a

This classification denotes an antibiotic with the molecular formula C66H103N17O16S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DDA3RRX0P7, chemically known as l-asparagine, n-(((4r)-2-((1s,2s)-1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-l-leucyl-d-.alpha.-glutamyl-l-isoleucyl-l-lysyl-d-ornithyl-l-isoleucyl-d-phenylalanyl-l-histidyl-d-.alpha.-aspartyl-, (10->4)-lactam, but more generally known as bacitracin a, which bears US NIH Compound Identifier 65281. European Medicines Agency schedules bacitracin a or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00652MIG. Most nations, for tariff purposes, schedule bacitracin a under HS 29419000. SMILES:. Bacitracin a bears US NLM identifiers UMLS ID C0052882 and NCI Concept Code C76238.